The Trump administration on Wednesday announced new a new plan to facilitate the importation of lower-cost prescription drugs from Canada, the Associated Press reports.
According to the report, it’s unclear when consumers could expect to benefit from such a proposal, as well as how Canada might respond.
“The landscape and the opportunities for safe linkage between drug supply chains has changed,” Health and Human Services Secretary Alex Azar said. “That is part of why, for the first time in HHS’s history, we are open to importation. We want to see proposals from states, distributors, and pharmacies that can help accomplish our shared goal of safe prescription drugs at lower costs.”
To read the full report on AP, click here.